date,title,source
Oct-24-18,"miRagen Therapeutics to Report Third Quarter 2018 Financial Results and Host Conference Call on November 7, 2018",GlobeNewswire
Oct-29-18,miRagen Therapeutics to Present at two Investor Conferences in November 2018,GlobeNewswire
Nov-01-18,Miragen Therapeutics to Present New Cobomarsen Phase 1 Clinical Trial Data at the 2018 American Society of Hematology Annual Meeting,GlobeNewswire
Nov-07-18,"Signal Genetics, Inc. (MGEN) Reports Q3 Loss, Misses Revenue Estimates",Zacks
Nov-07-18,miRagen Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update,GlobeNewswire
Dec-18-18,"Hedge Funds Are Crazy About Miragen Therapeutics, Inc. (MGEN)",Insider Monkey
Dec-20-18,miRagen Therapeutics to Present New Cobomarsen Clinical Trial Data for Adult T-Cell Leukemia/Lymphoma and Cutaneous T-Cell Lymphoma at the 11th Annual T-Cell Lymphoma Forum,GlobeNewswire
Jan-10-19,miRagen Announces New Clinical Data in Patients With Three Different Types of Blood Cancers Treated With Cobomarsen,GlobeNewswire
